Angiogenesis inhibitors in neuroendocrine tumours: finally coming of age

Lancet Oncol. 2020 Nov;21(11):1395-1397. doi: 10.1016/S1470-2045(20)30560-X.
No abstract available

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Humans
  • Neovascularization, Pathologic / genetics*
  • Neovascularization, Pathologic / pathology
  • Neovascularization, Pathologic / therapy
  • Neuroendocrine Tumors / epidemiology
  • Neuroendocrine Tumors / genetics
  • Neuroendocrine Tumors / pathology
  • Neuroendocrine Tumors / therapy*

Substances

  • Angiogenesis Inhibitors

Associated data

  • ClinicalTrials.gov/NCT01744249
  • ClinicalTrials.gov/NCT03375320